Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced December 2018.
Just six months after its $65m Series A financing, Akero Therapeutics Inc. has now raised $70m through a Series...








